GSK stops Ebola vaccine development, turns projects over to institute
Drug giant GlaxoSmithKline is stopping research into vaccines to treat Ebola and is turning over related projects to the Sabin Vaccine Institute.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
